Barclays PLC Lannett CO Inc Put Options Transaction History

Barclays PLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2018 Feb 14, 2019	SELL	$3.43 - $6.19 $1.59 Million - $2.87 Million	-463,000 Reduced 99.76%	1,100 $5,000
Q3 2018 Nov 14, 2018	SELL	$4.75 - $14.5 $2.43 Million - $7.42 Million	-511,500 Reduced 52.43%	464,100 $2.2 Million
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.45 $13 Million - $17 Million	975,600 New	975,600 $13.3 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.